RespireRx Pharmaceuticals Inc (RSPI)

[drfreely]

aoe. I don't think an investor willing to put up a million dollars in Corx stock would pay 3 cents a share. My guess would be more like 1.5 to 2.0 cents. If Margolis could convince a group to buy a half billion shares at 2 cents, that would raise a million (Minus legal and placement commission) for a trial, albeit a small one, tiny actually, with the hope that positive buzz from being back in clinic would increase the S.P. enough to sell more stock at a higher S.P.
But after the debacle of the last S.A. trial in England, and the disastrous dithering of the German number crunchers, I'm doubtful another small S.A. trial would generate enough positive momentum to propel the stock much above the 10 cent mark. You also have creditors and former management (no doubt more than a little peeved at having to accept small amounts of stock, and even less cash to settle their employment agreements) waiting to pounce and sell at the slightest uptick.
My guess is If they want to conduct a trial they'll have to find sources of funding other than printing/selling more stock certificates. Maybe N.I.H., or a license agreement. More loans from the Koreans. I'm sure they're looking at all options.